Residency · Residency · Physical Medicine & Rehabilitation
Cancer-Related Fatigue
Introduction
Cancer-related fatigue (CRF) is the most common symptom reported by cancer patients, affecting 60-90% during treatment and persisting in 30-40% of survivors for years after treatment completion. It is defined as a distressing, persistent sense of physical, emotional, or cognitive tiredness related to cancer or its treatment that is not proportional to recent activity and interferes with usual functioning.
Pathophysiology
Multifactorial Mechanisms
Proinflammatory cytokine dysregulation (IL-1, IL-6, TNF-alpha). Hypothalamic-pituitary-adrenal (HPA) axis disruption. Circadian rhythm disturbance and melatonin dysregulation. Skeletal muscle wasting and mitochondrial dysfunction.
Anemia and reduced oxygen-carrying capacity. Autonomic nervous system dysfunction. Central neurotransmitter changes (serotonin, dopamine).
Contributing Factors
Cancer treatment effects (chemotherapy, radiation, immunotherapy, surgery). Comorbid conditions: Anemia, thyroid dysfunction, depression, pain, sleep disorders. Nutritional deficiency and cachexia. Deconditioning from reduced physical activity. Medications (opioids, antiemetics, sedatives). Psychosocial distress.
Screening and Assessment
Screening Tools
Single-item screening: "Rate your fatigue 0-10 over past 7 days". Mild: 1-3; Moderate: 4-6; Severe: 7-10. NCCN recommends screening at every visit during and after treatment. Threshold for comprehensive evaluation: score 4 or greater.
Comprehensive Assessment Tools
Brief Fatigue Inventory (BFI): 9 items; validated in cancer populations. Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F). Multidimensional Fatigue Inventory (MFI). Cancer Fatigue Scale (CFS). Piper Fatigue Scale.
Reversible Causes Workup
Complete blood count (anemia: Hgb <10 g/dL). Thyroid function tests. Electrolytes, renal and hepatic function. Vitamin D, B12, iron studies. Depression and anxiety screening (PHQ-9, GAD-7). Sleep quality assessment. Medication review. Pain assessment. 
Management
Exercise (First-Line Intervention)
Most effective intervention for CRF with Level 1A evidence. Reduces fatigue by 40-50% during and after treatment. Aerobic exercise: 150 minutes/week moderate intensity (walking, cycling). Resistance training: 2-3 sessions/week.
Combination programs most effective. Safe during active treatment with appropriate precautions. Graded exercise approach with gradual progression.
Psychosocial Interventions
Cognitive behavioral therapy (CBT): Strong evidence for CRF. Psychoeducation on energy management. Stress reduction and coping strategies. Mindfulness-based stress reduction (MBSR). Support groups and peer counseling.
Energy Conservation
Activity pacing and prioritization. Delegate non-essential tasks. Plan activities during peak energy periods. Structured rest periods (avoid prolonged bed rest). Ergonomic modifications at home and work. Occupational therapy for adaptive strategies.
Pharmacological Interventions
Methylphenidate: Most studied psychostimulant; modest benefit. Modafinil/armodafinil: Mixed evidence; may help with severe fatigue. Corticosteroids (dexamethasone, methylprednisolone): Short-term benefit in advanced cancer. Treat reversible causes: Erythropoiesis-stimulating agents for chemotherapy-related anemia, thyroid replacement, antidepressants for comorbid depression. American ginseng: Some evidence in RCTs.
Nutritional Interventions
Adequate caloric and protein intake. Correct nutritional deficiencies (vitamin D, iron, B12). Hydration management. Anti-inflammatory dietary patterns. Referral to oncology dietitian. 
Special Considerations
During Active Treatment
Fatigue typically peaks 2-3 days after chemotherapy. Cumulative worsening over treatment cycles. Exercise adherence may require modification of intensity. Balance rest and activity; avoid prolonged inactivity.
Cancer Survivors
CRF persists in 30-40% for months to years post-treatment. Screen for late effects contributing to fatigue. Structured exercise programs for survivors. Return-to-work planning with gradual reintegration. Address cancer-related cognitive impairment ("chemobrain").
Palliative Setting
Corticosteroids for short-term energy improvement. Psychostimulants when appropriate. Focus on meaningful activity participation. Balance quality of life with symptom management. Caregiver education and support.
Outcomes Measurement
Track fatigue scores longitudinally. Functional measures: 6MWT, grip strength, TUG. Quality of life outcomes: FACT-G, EORTC QLQ-C30. Return to work and role function. Physical activity levels (accelerometry, activity logs).
Key Clinical Pearls
- Exercise is the most effective intervention for cancer-related fatigue, with stronger evidence than any pharmacological agent, and is safe during active treatment. 2. Screen for reversible contributing factors (anemia, thyroid dysfunction, depression, sleep disorders, vitamin deficiencies) before attributing fatigue solely to cancer or treatment. 3. Fatigue screening should be performed at every oncology visit using a simple 0-10 scale, with scores of 4 or greater triggering comprehensive evaluation. 4. Energy conservation and activity pacing are essential self-management strategies but should not replace structured exercise programs.
References
- Bower JE, Bak K, Berger A, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation. Journal of Clinical Oncology. 2014;32(17):1840-1850.
- Mustian KM, Alfano CM, Heckler C, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncology. 2017;3(7):961-968.
- National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: cancer-related fatigue. Version 2.2024.
- Berger AM, Mooney K, Alvarez-Perez A, et al. Cancer-related fatigue, version 2.2015. Journal of the National Comprehensive Cancer Network. 2015;13(8):1012-1039.
For the intern
At 3am, if a cancer patient reports severe fatigue (score 7-10), quickly assess for urgent reversible causes: severe anemia requiring transfusion (Hgb <7-8), acute infection, electrolyte abnormalities, or medication-related sedation. Check vitals and recent labs if available. Most cancer-related fatigue (CRF) management is non-urgent and better addressed during daytime rounds when you can coordinate with physical therapy, nutrition, and social work. Screen all cancer patients at morning rounds using a simple 0-10 scale; comprehensive workup and exercise prescription can wait for scheduled clinic visits.
Common pitfalls
- Attributing all fatigue to "just the cancer" without screening for treatable causes like anemia (Hgb <10), hypothyroidism, vitamin D deficiency, or depression—these are frequently missed opportunities for improvement
- Recommending only rest instead of prescribing structured exercise, which has the strongest evidence (Level 1A) for reducing CRF by 40-50% and is safe during active treatment
- Starting psychostimulants first without trying exercise and psychosocial interventions, which have better evidence and fewer side effects than methylphenidate or modafinil
- Using a score of 7+ as your intervention threshold when comprehensive evaluation should begin at fatigue scores of 4 or greater per NCCN guidelines—moderate fatigue significantly impacts function and warrants active management
Make it stick
Imagine Mrs. Rodriguez, a 62-year-old breast cancer survivor, coming to your PM&R clinic reporting persistent, debilitating fatigue since completing chemotherapy six months ago. She tearfully explains she can barely manage simple household chores, has stopped walking her beloved dog, and feels like she's lost herself. She's frustrated because her oncology team told her "it's normal after chemo" and to "just rest." As a PM&R intern, this is your moment. You know that while common, this level of fatigue isn't normal to ignore. You immediately start screening for reversible causes (anemia? thyroid? depression?), but critically, you introduce the idea of exercise. You explain that specialized physical therapy can gently rebuild her strength, restore energy, and help her reclaim her life—even during active treatment, exercise is the most potent medicine for cancer-related fatigue. Mrs. Rodriguez leaves with a glimmer of hope, understanding that activity, not just rest, is her path to recovery.
If you remember one thing
Exercise is the single most effective intervention for cancer-related fatigue (CRF), with the strongest evidence and efficacy, and it's safe during active treatment. Always screen for and address reversible causes, but remember: prescriptive rest is often the wrong answer for CRF.